Patent · US Active

Cancer immunotherapy by radiofrequency electrical membrane breakdown (RF-EMB)

US12295640B2 · kind B2 · utility

0Cited by
43References
15Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 23, 2020
Grant dateMay 13, 2025
Priority date
Expiry dateDec 14, 2043

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61M2205/054
  • WIPO fieldMedical technology
  • WIPO sectorInstruments

Abstract

A method of non-thermally ablating undesirable tissue in the body by application of pulsed, bipolar, instant charge reversal electrical fields of sufficient energy to cause complete and immediate cell membrane rupture and destruction. Energy is delivered through radio frequency pulses of particular frequencies, wave characteristics, pulse widths and pulse numbers, such that enhanced physical stresses are placed on the cell membrane to cause its immediate and complete destruction thereby spilling the entire cell content and membrane constituents into, the extracellular space without denaturing proteins so as to enable an immunological response to destroy and remove the target tissue and similarly marked tissue elsewhere in the subject.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.